Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115868) titled 'Effects of GABA with Butyrate, GABA/Butyrate-producing Synbiotics on Pain Relief in Fibromyalgia: A Phase II, Multi-Center, Double-Blinded, Randomized-Controlled Trial' on Dec. 31, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Chinese University of Hong Kong
Condition:
Fibromyalgia
Intervention:
GABA/Butyrate group:Purified GABA and butyrate in separately bottles respectively (Bottle 1 and Bottle 2). The patients will be instructed to take 1 capsule from Bottle 1 (500mg GABA) and 1 capsule from Bottle B (600mg Butyrate) twice a day, making it a total daily dose of 1gram...